icddr,b | Page 4 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Monday
September 22, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
MONDAY, SEPTEMBER 22, 2025

icddr,b

icddr,b

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi

India's Bharat Biotech seeks Bangladesh trial for Covid vaccine approved at home

If allowed to go ahead, this would be the first trial of any coronavirus vaccine in Bangladesh and could give the densely-populated country of more than 160 million faster access to the shot for...

File Photo: Small bottles labelled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo

icddr,b to hold human trial of Globe’s BANCOVID vaccine

File photo of icddr,b headquarters in Dhaka. Photo: Mumit M/TBS

icddr,b among five world labs to assess Covid vaccine response

icddr,b gets ‘home grown’ executive director

icddr,b gets ‘home grown’ executive director

File photo of icddr,b headquarters in Dhaka. Photo: Mumit M/TBS

Lockdown had economic, social costs for poorest families: icddr,b study

icddr.b in fund crisis

icddr.b in fund crisis

Lifesaver icddr,b now desperately seeks donations

Lifesaver icddr,b now desperately seeks donations

Photo: collected

Icddr,b to provide Covid-19-free certificates to foreigners

Photo: Reuters 

Bangladesh’s 4,200 health workers to join Chinese vaccine trial

Photo: collected

icddr,b to begin Covid-19 testing

Icddr,b begins clinical trial of Ivermectin to treat patients with Covid-19

Icddr,b begins clinical trial of Ivermectin to treat patients with Covid-19

Logo of Unilever. Picture: Collected

Unilever Bangladesh supports icddr,b’s ongoing Covid-19 emergency response

Harvesting of raw juice from a date palm by a juice collector. Photo: TBS

Nipah virus: IEDCR warns people not to drink raw date juice

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net